Entrada Therapeutics (TRDA) Stock Chart & Stock Price History → [BUY ALERT] Our #1 A.I. Stock for March (From Behind the Markets) (Ad) Free TRDA Stock Alerts $14.35 +0.59 (+4.29%) (As of 03/27/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Entrada Therapeutics Stock Price Performance5 Day Performance+4.59%1 Month Performance+10.47%3 Month Performance-12.55%6 Month Performance-11.31%Year-To-Date Performance-4.90%1 Year Performance-3.69% Receive TRDA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Entrada Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Behind the Markets[BUY ALERT] Our #1 A.I. Stock for MarchIt's the one AI stock nobody is talking about. Cathy Wood just bought 11 million shares of it.Get the name of the stock here - before it takes off >>> TRDA Stock Chart for Thursday, March, 28, 2024 TRDA Chart by TradingView Entrada Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization03/27/2024$13.76$14.35+4.29%$14.50$13.6646,082 shs$482.16 million03/26/2024$13.38$13.76+2.84%$14.00$13.2767,944 shs$462.34 million03/25/2024$13.72$13.38-2.48%$13.99$13.1238,641 shs$449.57 million03/22/2024$13.54$13.72+1.33%$13.96$13.3464,728 shs$460.99 million03/21/2024$13.35$13.54+1.42%$13.80$13.1171,898 shs$454.94 million03/20/2024$12.70$13.35+5.12%$13.53$12.3659,837 shs$448.56 million Get the Latest News and Ratings for TRDA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Entrada Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 03/19/2024$12.41$12.70+2.34%$12.97$12.2136,200 shs$426.73 million03/18/2024$12.78$12.41-2.90%$12.78$12.3347,845 shs$416.98 million03/15/2024$12.20$12.78+4.75%$12.81$12.09111,858 shs$426.47 million03/14/2024$12.71$12.20-4.01%$12.88$11.8790,555 shs$407.09 million03/13/2024$11.58$12.71+9.76%$12.82$11.35170,506 shs$424.13 million03/12/2024$11.76$11.58-1.53%$11.97$11.4374,657 shs$386.43 million03/11/2024$12.68$11.76-7.26%$12.70$11.6355,466 shs$392.43 million03/08/2024$12.58$12.68+0.79%$12.89$12.3243,125 shs$423.13 million03/07/2024$12.39$12.58+1.53%$12.88$12.2069,769 shs$419.80 million03/06/2024$12.28$12.39+0.90%$12.76$12.02104,101 shs$413.45 million03/05/2024$12.38$12.28-0.81%$13.32$11.92144,569 shs$409.76 million03/04/2024$13.73$12.38-9.83%$13.82$12.10107,735 shs$413.12 million03/01/2024$13.23$13.73+3.78%$13.73$13.13161,348 shs$458.17 million02/29/2024$12.99$13.23+1.85%$13.68$12.8998,097 shs$441.49 million02/28/2024$13.65$12.99-4.84%$13.95$12.8859,506 shs$433.48 million02/27/2024$13.82$13.65-1.23%$14.45$13.34114,666 shs$455.50 million02/26/2024$13.35$13.82+3.52%$13.96$13.16125,177 shs$461.17 million02/23/2024$13.24$13.35+0.83%$13.62$12.8993,528 shs$445.49 million02/22/2024$13.30$13.24-0.45%$13.57$12.89102,908 shs$441.82 million02/21/2024$13.62$13.30-2.35%$13.60$12.80107,575 shs$443.82 million02/20/2024$14.38$13.62-5.29%$14.55$13.4274,038 shs$454.47 million02/19/2024$14.38$14.38$15.06$14.0675,400 shs$479.86 million02/16/2024$15.02$14.38-4.26%$15.06$14.0675,439 shs$479.86 million02/15/2024$14.75$15.02+1.83%$15.49$14.5969,118 shs$501.19 million02/14/2024$13.91$14.75+6.04%$14.85$13.7768,311 shs$492.21 million02/13/2024$15.17$13.91-8.31%$14.75$13.6270,917 shs$464.18 million02/12/2024$15.13$15.17+0.26%$15.57$14.7082,286 shs$506.22 million02/09/2024$14.51$15.13+4.27%$15.31$14.5043,427 shs$504.89 million02/08/2024$13.85$14.51+4.77%$14.56$13.9725,442 shs$484.20 million02/07/2024$14.17$13.85-2.26%$14.32$13.5154,143 shs$462.17 million02/06/2024$14.32$14.17-1.05%$14.85$13.7858,530 shs$472.85 million02/05/2024$14.72$14.32-2.72%$14.70$14.3135,471 shs$477.83 million02/02/2024$14.77$14.72-0.34%$15.15$14.5826,469 shs$491.21 million02/01/2024$14.57$14.77+1.37%$15.19$14.0969,030 shs$492.88 million[BUY ALERT] Our #1 A.I. Stock for March (Ad)It's the one AI stock nobody is talking about. Cathy Wood just bought 11 million shares of it.Get the name of the stock here - before it takes off >>>01/31/2024$15.34$14.57-5.02%$15.50$14.5742,371 shs$511.87 million01/30/2024$15.22$15.34+0.79%$15.60$14.8436,478 shs$511.90 million01/29/2024$14.83$15.22+2.63%$15.27$14.60101,383 shs$507.89 million01/26/2024$14.90$14.83-0.47%$15.50$14.4438,614 shs$494.85 million01/25/2024$15.48$14.90-3.75%$15.48$14.1542,250 shs$497.21 million01/24/2024$16.04$15.48-3.49%$16.47$15.4332,207 shs$516.57 million01/23/2024$15.67$16.04+2.39%$16.50$15.7435,252 shs$535.26 million01/22/2024$14.65$15.67+6.93%$15.85$14.8993,790 shs$522.74 million01/19/2024$14.99$14.65-2.27%$15.07$13.97204,826 shs$488.87 million01/18/2024$15.51$14.99-3.35%$15.72$14.5536,120 shs$500.22 million01/17/2024$14.93$15.51+3.88%$15.70$14.5467,512 shs$517.57 million01/16/2024$16.37$14.93-8.80%$16.07$14.7186,633 shs$498.18 million01/15/2024$16.37$16.37$16.94$15.8558,100 shs$546.27 million01/12/2024$16.13$16.37+1.49%$16.92$15.8558,076 shs$546.27 million01/11/2024$16.48$16.13-2.12%$16.60$15.9171,291 shs$538.23 million01/10/2024$17.00$16.48-3.06%$17.05$16.0966,561 shs$549.94 million01/09/2024$15.80$17.00+7.59%$17.26$15.50121,407 shs$567.29 million01/08/2024$15.25$15.80+3.61%$16.27$14.9487,284 shs$527.25 million01/05/2024$14.06$15.25+8.46%$16.21$13.70123,914 shs$469.15 million01/04/2024$13.80$14.06+1.88%$14.75$13.8786,265 shs$469.18 million01/03/2024$15.17$13.80-9.03%$15.28$13.54112,232 shs$460.51 million01/02/2024$15.09$15.17+0.53%$15.96$14.8581,738 shs$506.22 million01/01/2024$15.09$15.09$16.92$14.95101,300 shs$503.55 million12/29/2023$16.41$15.09-8.04%$16.92$14.95101,344 shs$503.55 million12/28/2023$16.89$16.41-2.84%$17.56$16.1963,036 shs$547.60 million12/27/2023$16.69$16.89+1.20%$17.10$16.3646,042 shs$563.62 million Related Companies: Theravance Biopharma Stock Price Chart Oculis Stock Price Chart Revance Therapeutics Stock Price Chart Nuvation Bio Stock Price Chart ESSA Pharma Stock Price Chart Heron Therapeutics Stock Price Chart Avid Bioservices Stock Price Chart Corbus Pharmaceuticals Stock Price Chart PepGen Stock Price Chart Shattuck Labs Stock Price Chart Receive TRDA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Entrada Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:TRDA) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBREAKING: New AI Breakthrough Could Change Healthcare ForeverBehind the Markets“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisorySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceBuy this small stock before coming AI Tidal WaveChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Entrada Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.